Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,748,840
+$3,515,190 QoQ
Shares Held
13,964
-2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#979
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fiduciary Trust Co holds $270,904,336 across 13 Drug Manufacturers - General names. LLY ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
317,105 | $80,535,156 | |
| 2 | ABBV |
AbbVie Inc.
|
303,294 | $76,320,901 | |
| 3 | MRK |
Merck & Co., Inc.
|
401,189 | $51,552,786 | |
| 4 | AMGN |
Amgen Inc
|
49,645 | $17,977,447 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
13,964 | $16,748,840 | |
| 6 | NVS |
Novartis AG
|
47,417 | $7,431,191 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
120,039 | $6,916,646 | |
| 8 | PFE |
Pfizer Inc
|
251,314 | $6,051,640 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,748,840 | 13,964 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $13,233,650 | 14,388 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,115,375 | 14,065 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,061,211 | 14,497 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,669,932 | 11,122 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,134,386 | 9,849 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,210,480 | 9,340 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,584,531 | 8,561 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,278,349 | 8,039 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,540,630 | 7,122 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,099,675 | 7,033 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,909,768 | 7,279 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,590,510 | 7,656 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,560,882 | 7,457 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,499,784 | 6,833 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,059,739 | 6,370 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,959,321 | 6,043 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,763,752 | 6,159 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,770,570 | 6,410 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,514,763 | 6,556 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,551,783 | 6,761 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,717,249 | 9,192 | Shares | Sole | 2021-05-19 | |
| 2020-12-31 | $1,586,757 | 9,398 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,502,254 | 10,149 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,875,099 | 11,421 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,575,303 | 11,356 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||